Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase

Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brai...

Full description

Saved in:

Bibliographic Details
Published in:	PLoS pathogens Vol. 12; no. 5; p. e1005615
Main Authors:	Huang, Lei, Ou, Rong, Rabelo de Souza, Guilherme, Cunha, Thiago M., Lemos, Henrique, Mohamed, Eslam, Li, Lingqian, Pacholczyk, Gabriela, Randall, Janice, Munn, David H., Mellor, Andrew L.
Format:	Journal Article
Language:	English
Published:	United States Public Library of Science 01.05.2016 Public Library of Science (PLoS)
Subjects:	Animals Biology and Life Sciences Brain research Cytokines Disease Models, Animal Enzymes Experiments Flow Cytometry Genetic aspects Health aspects HIV Human immunodeficiency virus Hyperalgesia - enzymology Hyperalgesia - etiology Hypersensitivity Hypotheses Indoleamine-Pyrrole 2,3,-Dioxygenase - biosynthesis Infections Inflammation Influenza Influenza A virus Kynurenine - metabolism Laboratory animals Leukemia Medicine and Health Sciences Mice Orthomyxoviridae Pain Pain management Physiological aspects Polymerase Chain Reaction Research and Analysis Methods Retroviridae Rodents Spinal cord Spleen Tryptophan Virus diseases Virus Diseases - complications Viruses
ISSN:	1553-7374, 1553-7366, 1553-7374
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brain mediated by indoleamine 2,3 dioxygenase (IDO). Here we show that acute influenza A virus (IAV) and chronic murine leukemia retrovirus (MuLV) infections, which stimulate robust IDO expression in lungs and lymphoid tissues, induced acute or chronic pain hypersensitivity, respectively. In contrast, virus-induced pain hypersensitivity did not manifest in mice lacking intact IDO1 genes. Spleen IDO activity increased markedly as MuLV infections progressed, while IDO1 expression was not elevated significantly in brain or spinal cord (CNS) tissues. Moreover, kynurenine (Kyn), a tryptophan catabolite made by cells expressing IDO, incited pain hypersensitivity in uninfected IDO1-deficient mice and Kyn potentiated pain hypersensitivity due to MuLV infection. MuLV infection stimulated selective IDO expression by a discreet population of spleen cells expressing both B cell (CD19) and dendritic cell (CD11c) markers (CD19+ DCs). CD19+ DCs were more susceptible to MuLV infection than B cells or conventional (CD19neg) DCs, proliferated faster than B cells from early stages of MuLV infection and exhibited mature antigen presenting cell (APC) phenotypes, unlike conventional (CD19neg) DCs. Moreover, interactions with CD4 T cells were necessary to sustain functional IDO expression by CD19+ DCs in vitro and in vivo. Splenocytes from MuLV-infected IDO1-sufficient mice induced pain hypersensitivity in uninfected IDO1-deficient recipient mice, while selective in vivo depletion of DCs alleviated pain hypersensitivity in MuLV-infected IDO1-sufficient mice and led to rapid reduction in splenomegaly, a hallmark of MuLV immune pathogenesis. These findings reveal critical roles for CD19+ DCs expressing IDO in host responses to MuLV infection that enhance pain hypersensitivity and cause immune pathology. Collectively, our findings support the hypothesis elevated IDO activity in non-CNS due to virus infections causes pain hypersensitivity mediated by Kyn. Previously unappreciated links between host immune responses to virus infections and pain sensitivity suggest that IDO inhibitors may alleviate heightened pain sensitivity during infections.
AbstractList	Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brain mediated by indoleamine 2,3 dioxygenase (IDO). Here we show that acute influenza A virus (IAV) and chronic murine leukemia retrovirus (MuLV) infections, which stimulate robust IDO expression in lungs and lymphoid tissues, induced acute or chronic pain hypersensitivity, respectively. In contrast, virus-induced pain hypersensitivity did not manifest in mice lacking intact IDO1 genes. Spleen IDO activity increased markedly as MuLV infections progressed, while IDO1 expression was not elevated significantly in brain or spinal cord (CNS) tissues. Moreover, kynurenine (Kyn), a tryptophan catabolite made by cells expressing IDO, incited pain hypersensitivity in uninfected IDO1-deficient mice and Kyn potentiated pain hypersensitivity due to MuLV infection. MuLV infection stimulated selective IDO expression by a discreet population of spleen cells expressing both B cell (CD19) and dendritic cell (CD11c) markers (CD19+ DCs). CD19+ DCs were more susceptible to MuLV infection than B cells or conventional (CD19neg) DCs, proliferated faster than B cells from early stages of MuLV infection and exhibited mature antigen presenting cell (APC) phenotypes, unlike conventional (CD19neg) DCs. Moreover, interactions with CD4 T cells were necessary to sustain functional IDO expression by CD19+ DCs in vitro and in vivo. Splenocytes from MuLV-infected IDO1-sufficient mice induced pain hypersensitivity in uninfected IDO1-deficient recipient mice, while selective in vivo depletion of DCs alleviated pain hypersensitivity in MuLV-infected IDO1-sufficient mice and led to rapid reduction in splenomegaly, a hallmark of MuLV immune pathogenesis. These findings reveal critical roles for CD19+ DCs expressing IDO in host responses to MuLV infection that enhance pain hypersensitivity and cause immune pathology. Collectively, our findings support the hypothesis elevated IDO activity in non-CNS due to virus infections causes pain hypersensitivity mediated by Kyn. Previously unappreciated links between host immune responses to virus infections and pain sensitivity suggest that IDO inhibitors may alleviate heightened pain sensitivity during infections. Chronic pain is a factor in diseases that afflict many people, yet the underlying causes of pain are poorly understood. Here we assess the effects of virus infections on pain sensitivity in mice. Infecting mice with two different viruses, influenza and mouse leukemia virus (MuLV) increased pain sensitivity. Influenza infection caused transient increase in pain sensitivity, which returned to normal levels after infections were cleared. However persistent MuLV infections caused sustained increase in pain sensitivity. Virus-induced pain sensitivity was reduced substantially in mice lacking the enzyme indoleamine 2,3 dioxygenase (IDO), which degrades the amino acid tryptophan. Moreover a natural compound produced by cells expressing IDO enhanced pain sensitivity when administered to mice lacking IDO genes. Thus cells expressing IDO caused increased pain sensitivity in infected mice. A distinctive cell type expressed IDO selectively and accumulated in spleens of MuLV-infected mice. Transfer of spleen cells from MuLV-infected mice caused increased pain sensitivity in uninfected mice while eliminating specific cells in MuLV-infected mice abolished enhanced pain sensitivity. Our findings show that host immune responses to virus infections cause increased pain sensitivity and suggest novel ways to alleviate pain during infections. Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brain mediated by indoleamine 2,3 dioxygenase (IDO). Here we show that acute influenza A virus (IAV) and chronic murine leukemia retrovirus (MuLV) infections, which stimulate robust IDO expression in lungs and lymphoid tissues, induced acute or chronic pain hypersensitivity, respectively. In contrast, virus-induced pain hypersensitivity did not manifest in mice lacking intact IDO1 genes. Spleen IDO activity increased markedly as MuLV infections progressed, while IDO1 expression was not elevated significantly in brain or spinal cord (CNS) tissues. Moreover, kynurenine (Kyn), a tryptophan catabolite made by cells expressing IDO, incited pain hypersensitivity in uninfected IDO1-deficient mice and Kyn potentiated pain hypersensitivity due to MuLV infection. MuLV infection stimulated selective IDO expression by a discreet population of spleen cells expressing both B cell (CD19) and dendritic cell (CD11c) markers (CD19.sup.+ DCs). CD19.sup.+ DCs were more susceptible to MuLV infection than B cells or conventional (CD19.sup.neg) DCs, proliferated faster than B cells from early stages of MuLV infection and exhibited mature antigen presenting cell (APC) phenotypes, unlike conventional (CD19.sup.neg) DCs. Moreover, interactions with CD4 T cells were necessary to sustain functional IDO expression by CD19.sup.+ DCs in vitro and in vivo. Splenocytes from MuLV-infected IDO1-sufficient mice induced pain hypersensitivity in uninfected IDO1-deficient recipient mice, while selective in vivo depletion of DCs alleviated pain hypersensitivity in MuLV-infected IDO1-sufficient mice and led to rapid reduction in splenomegaly, a hallmark of MuLV immune pathogenesis. These findings reveal critical roles for CD19.sup.+ DCs expressing IDO in host responses to MuLV infection that enhance pain hypersensitivity and cause immune pathology. Collectively, our findings support the hypothesis elevated IDO activity in non-CNS due to virus infections causes pain hypersensitivity mediated by Kyn. Previously unappreciated links between host immune responses to virus infections and pain sensitivity suggest that IDO inhibitors may alleviate heightened pain sensitivity during infections. Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brain mediated by indoleamine 2,3 dioxygenase (IDO). Here we show that acute influenza A virus (IAV) and chronic murine leukemia retrovirus (MuLV) infections, which stimulate robust IDO expression in lungs and lymphoid tissues, induced acute or chronic pain hypersensitivity, respectively. In contrast, virus-induced pain hypersensitivity did not manifest in mice lacking intact IDO1 genes. Spleen IDO activity increased markedly as MuLV infections progressed, while IDO1 expression was not elevated significantly in brain or spinal cord (CNS) tissues. Moreover, kynurenine (Kyn), a tryptophan catabolite made by cells expressing IDO, incited pain hypersensitivity in uninfected IDO1-deficient mice and Kyn potentiated pain hypersensitivity due to MuLV infection. MuLV infection stimulated selective IDO expression by a discreet population of spleen cells expressing both B cell (CD19) and dendritic cell (CD11c) markers (CD19+ DCs). CD19+ DCs were more susceptible to MuLV infection than B cells or conventional (CD19neg) DCs, proliferated faster than B cells from early stages of MuLV infection and exhibited mature antigen presenting cell (APC) phenotypes, unlike conventional (CD19neg) DCs. Moreover, interactions with CD4 T cells were necessary to sustain functional IDO expression by CD19+ DCs in vitro and in vivo. Splenocytes from MuLV-infected IDO1-sufficient mice induced pain hypersensitivity in uninfected IDO1-deficient recipient mice, while selective in vivo depletion of DCs alleviated pain hypersensitivity in MuLV-infected IDO1-sufficient mice and led to rapid reduction in splenomegaly, a hallmark of MuLV immune pathogenesis. These findings reveal critical roles for CD19+ DCs expressing IDO in host responses to MuLV infection that enhance pain hypersensitivity and cause immune pathology. Collectively, our findings support the hypothesis elevated IDO activity in non-CNS due to virus infections causes pain hypersensitivity mediated by Kyn. Previously unappreciated links between host immune responses to virus infections and pain sensitivity suggest that IDO inhibitors may alleviate heightened pain sensitivity during infections. Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brain mediated by indoleamine 2,3 dioxygenase (IDO). Here we show that acute influenza A virus (IAV) and chronic murine leukemia retrovirus (MuLV) infections, which stimulate robust IDO expression in lungs and lymphoid tissues, induced acute or chronic pain hypersensitivity, respectively. In contrast, virus-induced pain hypersensitivity did not manifest in mice lacking intact IDO1 genes. Spleen IDO activity increased markedly as MuLV infections progressed, while IDO1 expression was not elevated significantly in brain or spinal cord (CNS) tissues. Moreover, kynurenine (Kyn), a tryptophan catabolite made by cells expressing IDO, incited pain hypersensitivity in uninfected IDO1-deficient mice and Kyn potentiated pain hypersensitivity due to MuLV infection. MuLV infection stimulated selective IDO expression by a discreet population of spleen cells expressing both B cell (CD19) and dendritic cell (CD11c) markers (CD19+ DCs). CD19+ DCs were more susceptible to MuLV infection than B cells or conventional (CD19neg) DCs, proliferated faster than B cells from early stages of MuLV infection and exhibited mature antigen presenting cell (APC) phenotypes, unlike conventional (CD19neg) DCs. Moreover, interactions with CD4 T cells were necessary to sustain functional IDO expression by CD19+ DCs in vitro and in vivo. Splenocytes from MuLV-infected IDO1-sufficient mice induced pain hypersensitivity in uninfected IDO1-deficient recipient mice, while selective in vivo depletion of DCs alleviated pain hypersensitivity in MuLV-infected IDO1-sufficient mice and led to rapid reduction in splenomegaly, a hallmark of MuLV immune pathogenesis. These findings reveal critical roles for CD19+ DCs expressing IDO in host responses to MuLV infection that enhance pain hypersensitivity and cause immune pathology. Collectively, our findings support the hypothesis elevated IDO activity in non-CNS due to virus infections causes pain hypersensitivity mediated by Kyn. Previously unappreciated links between host immune responses to virus infections and pain sensitivity suggest that IDO inhibitors may alleviate heightened pain sensitivity during infections.Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brain mediated by indoleamine 2,3 dioxygenase (IDO). Here we show that acute influenza A virus (IAV) and chronic murine leukemia retrovirus (MuLV) infections, which stimulate robust IDO expression in lungs and lymphoid tissues, induced acute or chronic pain hypersensitivity, respectively. In contrast, virus-induced pain hypersensitivity did not manifest in mice lacking intact IDO1 genes. Spleen IDO activity increased markedly as MuLV infections progressed, while IDO1 expression was not elevated significantly in brain or spinal cord (CNS) tissues. Moreover, kynurenine (Kyn), a tryptophan catabolite made by cells expressing IDO, incited pain hypersensitivity in uninfected IDO1-deficient mice and Kyn potentiated pain hypersensitivity due to MuLV infection. MuLV infection stimulated selective IDO expression by a discreet population of spleen cells expressing both B cell (CD19) and dendritic cell (CD11c) markers (CD19+ DCs). CD19+ DCs were more susceptible to MuLV infection than B cells or conventional (CD19neg) DCs, proliferated faster than B cells from early stages of MuLV infection and exhibited mature antigen presenting cell (APC) phenotypes, unlike conventional (CD19neg) DCs. Moreover, interactions with CD4 T cells were necessary to sustain functional IDO expression by CD19+ DCs in vitro and in vivo. Splenocytes from MuLV-infected IDO1-sufficient mice induced pain hypersensitivity in uninfected IDO1-deficient recipient mice, while selective in vivo depletion of DCs alleviated pain hypersensitivity in MuLV-infected IDO1-sufficient mice and led to rapid reduction in splenomegaly, a hallmark of MuLV immune pathogenesis. These findings reveal critical roles for CD19+ DCs expressing IDO in host responses to MuLV infection that enhance pain hypersensitivity and cause immune pathology. Collectively, our findings support the hypothesis elevated IDO activity in non-CNS due to virus infections causes pain hypersensitivity mediated by Kyn. Previously unappreciated links between host immune responses to virus infections and pain sensitivity suggest that IDO inhibitors may alleviate heightened pain sensitivity during infections. Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain hypersensitivity in rodents treated to induce chronic inflammation in peripheral tissues was linked to enhanced tryptophan catabolism in brain mediated by indoleamine 2,3 dioxygenase (IDO). Here we show that acute influenza A virus (IAV) and chronic murine leukemia retrovirus (MuLV) infections, which stimulate robust IDO expression in lungs and lymphoid tissues, induced acute or chronic pain hypersensitivity, respectively. In contrast, virus-induced pain hypersensitivity did not manifest in mice lacking intact IDO1 genes. Spleen IDO activity increased markedly as MuLV infections progressed, while IDO1 expression was not elevated significantly in brain or spinal cord (CNS) tissues. Moreover, kynurenine (Kyn), a tryptophan catabolite made by cells expressing IDO, incited pain hypersensitivity in uninfected IDO1-deficient mice and Kyn potentiated pain hypersensitivity due to MuLV infection. MuLV infection stimulated selective IDO expression by a discreet population of spleen cells expressing both B cell (CD19) and dendritic cell (CD11c) markers (CD19+ DCs). CD19+ DCs were more susceptible to MuLV infection than B cells or conventional (CD19neg) DCs, proliferated faster than B cells from early stages of MuLV infection and exhibited mature antigen presenting cell (APC) phenotypes, unlike conventional (CD19neg) DCs. Moreover, interactions with CD4 T cells were necessary to sustain functional IDO expression by CD19+ DCs in vitro and in vivo. Splenocytes from MuLV-infected IDO1-sufficient mice induced pain hypersensitivity in uninfected IDO1-deficient recipient mice, while selective in vivo depletion of DCs alleviated pain hypersensitivity in MuLV-infected IDO1-sufficient mice and led to rapid reduction in splenomegaly, a hallmark of MuLV immune pathogenesis. These findings reveal critical roles for CD19+ DCs expressing IDO in host responses to MuLV infection that enhance pain hypersensitivity and cause immune pathology. Collectively, our findings support the hypothesis elevated IDO activity in non-CNS due to virus infections causes pain hypersensitivity mediated by Kyn. Previously unappreciated links between host immune responses to virus infections and pain sensitivity suggest that IDO inhibitors may alleviate heightened pain sensitivity during infections.
Audience	Academic
Author	Lemos, Henrique Munn, David H. Huang, Lei Ou, Rong Randall, Janice Mohamed, Eslam Rabelo de Souza, Guilherme Li, Lingqian Pacholczyk, Gabriela Mellor, Andrew L. Cunha, Thiago M.
AuthorAffiliation	2 Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil 1 Cancer Immunology, Inflammation and Tolerance Program, Cancer Center, Augusta University, Augusta, Georgia, United States of America Icahn School of Medicine at Mount Sinai, UNITED STATES
AuthorAffiliation_xml	– name: 1 Cancer Immunology, Inflammation and Tolerance Program, Cancer Center, Augusta University, Augusta, Georgia, United States of America – name: Icahn School of Medicine at Mount Sinai, UNITED STATES – name: 2 Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
Author_xml	– sequence: 1 givenname: Lei surname: Huang fullname: Huang, Lei – sequence: 2 givenname: Rong surname: Ou fullname: Ou, Rong – sequence: 3 givenname: Guilherme surname: Rabelo de Souza fullname: Rabelo de Souza, Guilherme – sequence: 4 givenname: Thiago M. surname: Cunha fullname: Cunha, Thiago M. – sequence: 5 givenname: Henrique surname: Lemos fullname: Lemos, Henrique – sequence: 6 givenname: Eslam surname: Mohamed fullname: Mohamed, Eslam – sequence: 7 givenname: Lingqian surname: Li fullname: Li, Lingqian – sequence: 8 givenname: Gabriela surname: Pacholczyk fullname: Pacholczyk, Gabriela – sequence: 9 givenname: Janice surname: Randall fullname: Randall, Janice – sequence: 10 givenname: David H. surname: Munn fullname: Munn, David H. – sequence: 11 givenname: Andrew L. surname: Mellor fullname: Mellor, Andrew L.
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27168185$$D View this record in MEDLINE/PubMed
BookMark	eNqVk2trFDEUhgep2Iv-A9EFvyi4azK594NQ6qULRUWtX0M2czJmmU3WyUzp_nsz7rR0S1FkIHNInvPm5OWcw2IvxABF8RSjGSYCv1nGvg2mma3XppthhBjH7EFxgBkjU0EE3bsV7xeHKS0Rophg_qjYLwXmEkt2UFz88G2fJvPgwHY-hiG0voPJF-PD5GyzhjZBSL7zl77bTBabfF711od6CGIDZuUDTMrXZPLOx6tNDcEkeFw8dKZJ8GT8HxUXH95_Pz2bnn_-OD89OZ9armg3tQKXGBNwIK1itmKmctKVwBB2FKByJReG0AXjAmPFBMo4Usgoi7lxqiJHxfOt7rqJSY-OJI2FEgxRRstMzLdEFc1Sr1u_Mu1GR-P1n43Y1tq0nbcNaI4Iw7JyXFaMWmllKUvk1IITUSLOIGu9HW_rFyuoLISuNc2O6O5J8D91HS81lZwoPhTzchRo468eUqdXPlloGhMg9rluiTIplKL_RoVUiIi8ZvTFHfR-I0aqNvmtPriYS7SDqD6hQjFSKjZcO7uHyl8FK29zAzqf93cSXu0kZKaDq642fUp6_u3rf7Cfdtlnt72-Mfm6czNAt4BtY0otuBsEIz0MyLULehgQPQ5ITju-k5a73Qydnx_qm78n_wYQBRU1
CitedBy_id	crossref_primary_10_1097_PR9_0000000000000885 crossref_primary_10_1038_s41380_019_0414_4 crossref_primary_10_1016_j_pharmthera_2021_108055 crossref_primary_10_1016_j_imlet_2020_11_009 crossref_primary_10_3389_fimmu_2019_02570 crossref_primary_10_1111_febs_13966 crossref_primary_10_3389_fimmu_2020_01256 crossref_primary_10_4103_0028_3886_344625 crossref_primary_10_1136_bmjmed_2021_000108 crossref_primary_10_3390_cells13151259 crossref_primary_10_3390_jcm13020597 crossref_primary_10_1016_j_jpsychores_2022_111069 crossref_primary_10_4102_ojvr_v87i1_1871 crossref_primary_10_4102_ojvr_v88i1_1871 crossref_primary_10_1016_j_pharmthera_2021_107845 crossref_primary_10_1016_j_ynpai_2020_100056 crossref_primary_10_3389_fvets_2020_00646 crossref_primary_10_3390_v8100269 crossref_primary_10_1016_j_canlet_2019_07_017 crossref_primary_10_1007_s12264_017_0098_1 crossref_primary_10_1038_s41590_018_0299_4 crossref_primary_10_3390_ijms21176045 crossref_primary_10_1016_j_pmn_2023_04_010 crossref_primary_10_1016_j_biopha_2025_118054 crossref_primary_10_7759_cureus_82579 crossref_primary_10_7554_eLife_55582 crossref_primary_10_3389_fpain_2025_1527106 crossref_primary_10_1016_j_micres_2025_128211 crossref_primary_10_3389_fnins_2020_00620 crossref_primary_10_1172_JCI153805 crossref_primary_10_3389_fonc_2018_00370 crossref_primary_10_1016_j_bbagrm_2016_09_005 crossref_primary_10_1016_j_bbi_2024_07_013 crossref_primary_10_1089_vim_2016_0125 crossref_primary_10_1007_s11926_023_01107_8 crossref_primary_10_1523_JNEUROSCI_3055_19_2020 crossref_primary_10_1007_s40122_020_00175_3 crossref_primary_10_1016_j_arr_2022_101573 crossref_primary_10_1016_j_canlet_2024_217399 crossref_primary_10_1111_febs_13997 crossref_primary_10_1111_febs_15613 crossref_primary_10_1002_ehf2_14003 crossref_primary_10_3389_fnmol_2023_1156674 crossref_primary_10_1016_j_mayocp_2020_12_014 crossref_primary_10_3389_fimmu_2016_00605
Cites_doi	10.1126/science.1073514 10.1016/S0166-0934(02)00256-2 10.4049/jimmunol.175.9.5601 10.1097/00002030-199207000-00001 10.4049/jimmunol.0901150 10.1186/1743-422X-10-154 10.1128/JVI.65.12.6562-6571.1991 10.1097/WCO.0b013e328364c036 10.1371/journal.pone.0066546 10.4049/jimmunol.181.8.5396 10.1093/intimm/dxh271 10.1016/0042-6822(70)90362-4 10.1172/JCI200421583 10.1111/j.1600-065X.1999.tb01298.x 10.1038/ni1003 10.1128/JVI.71.4.3013-3022.1997 10.1016/j.jneuroim.2013.04.023 10.1016/0304-3959(94)90013-2 10.4049/jimmunol.1201313 10.1073/pnas.0914347107 10.4049/jimmunol.1301419 10.2165/11630030-000000000-00000 10.1182/blood-2011-01-331462 10.1016/j.cell.2014.07.051 10.1016/j.leukres.2008.05.023 10.1016/S0304-3959(00)00276-1 10.1111/j.1471-4159.1991.tb03460.x 10.1093/intimm/dxh140 10.1084/jem.171.1.315 10.4049/jimmunol.0901322 10.1016/j.bbi.2015.01.013 10.1172/JCI61884 10.4049/jimmunol.1103668 10.2165/11630070-000000000-00000 10.2174/138920007780362608 10.1046/j.1600-6135.2003.00246.x
ContentType	Journal Article
Copyright	COPYRIGHT 2016 Public Library of Science 2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Huang L, Ou R, Rabelo de Souza G, Cunha TM, Lemos H, Mohamed E, et al. (2016) Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase. PLoS Pathog 12(5): e1005615. doi:10.1371/journal.ppat.1005615 2016 Huang et al 2016 Huang et al 2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Huang L, Ou R, Rabelo de Souza G, Cunha TM, Lemos H, Mohamed E, et al. (2016) Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase. PLoS Pathog 12(5): e1005615. doi:10.1371/journal.ppat.1005615
Copyright_xml	– notice: COPYRIGHT 2016 Public Library of Science – notice: 2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Huang L, Ou R, Rabelo de Souza G, Cunha TM, Lemos H, Mohamed E, et al. (2016) Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase. PLoS Pathog 12(5): e1005615. doi:10.1371/journal.ppat.1005615 – notice: 2016 Huang et al 2016 Huang et al – notice: 2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Huang L, Ou R, Rabelo de Souza G, Cunha TM, Lemos H, Mohamed E, et al. (2016) Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase. PLoS Pathog 12(5): e1005615. doi:10.1371/journal.ppat.1005615
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM ISN ISR 3V. 7QL 7U9 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7T5 5PM DOA
DOI	10.1371/journal.ppat.1005615
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Immunology Abstracts PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Immunology Abstracts
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
DocumentTitleAlternate	Virus Infections Induce Pain via IDO
EISSN	1553-7374
ExternalDocumentID	1797504542 oai_doaj_org_article_603518df68d54c8c82820f9b6372065e PMC4863962 4091682401 A479532954 27168185 10_1371_journal_ppat_1005615
Genre	Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NCI NIH HHS grantid: R01 CA103320 – fundername: NIAID NIH HHS grantid: R01 AI103347 – fundername: NCI NIH HHS grantid: R01 CA096651 – fundername: NIAID NIH HHS grantid: U01 AI083005 – fundername: ; – fundername: ; grantid: 2013/08216-2 – fundername: ; grantid: AI083005 – fundername: ; grantid: Research Internship Abroad (BEPE) – fundername: ; grantid: AI103347 – fundername: ; grantid: 2011/19670-0
GroupedDBID	--- 123 29O 2WC 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAUCC AAWOE AAYXX ABDBF ABUWG ACCTH ACGFO ACIHN ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAIFH BAWUL BBNVY BBTPI BCNDV BENPR BHPHI BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ISN ISR ITC KQ8 LK8 M1P M48 M7P MM. O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PV9 QF4 QN7 RNS RPM RZL SV3 TR2 TUS UKHRP WOW ~8M CGR CUY CVF ECM EIF H13 IPNFZ NPM RIG WOQ 3V. 7QL 7U9 7XB 8FK AZQEC C1K DWQXO GNUQQ H94 K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 7T5 5PM AAPBV ABPTK M~E
ID	FETCH-LOGICAL-c694t-c712113efe8c95cd5adf8f2e501f4eedf267a34b567119570121090a9c16af9d3
IEDL.DBID	M7P
ISICitedReferencesCount	49
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000379344500023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1553-7374 1553-7366
IngestDate	Sun Aug 06 00:38:03 EDT 2023 Fri Oct 03 12:47:22 EDT 2025 Tue Nov 04 01:51:48 EST 2025 Thu Oct 02 10:57:32 EDT 2025 Thu Oct 02 11:51:52 EDT 2025 Sat Nov 29 14:41:18 EST 2025 Tue Nov 11 10:14:24 EST 2025 Tue Nov 04 17:46:56 EST 2025 Thu Nov 13 14:50:14 EST 2025 Thu Nov 13 15:46:32 EST 2025 Mon Jul 21 05:32:18 EDT 2025 Sat Nov 29 03:38:07 EST 2025 Tue Nov 18 21:29:51 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	5
Language	English
License	This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c694t-c712113efe8c95cd5adf8f2e501f4eedf267a34b567119570121090a9c16af9d3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Current address: Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle-upon-Tyne, NE2 4HH, UK. Conceived and designed the experiments: LH GRdS ALM. Performed the experiments: LH RO GRdS HL EM LL GP JR. Analyzed the data: LH RO GRdS TMC HL EM LL DHM ALM. Wrote the paper: LH TMC DHM ALM. I have read the journal's policy and the authors of this manuscript have the following competing interests: ALM and DHM serve as consultants for NewLink Genetics Inc. and receive remuneration from this source. The authors declare no additional competing financial interests. This does not alter our adherence to all PLOS policies on sharing data and materials.
OpenAccessLink	https://www.proquest.com/docview/1797504542?pq-origsite=%requestingapplication%
PMID	27168185
PQID	1797504542
PQPubID	1436335
ParticipantIDs	plos_journals_1797504542 doaj_primary_oai_doaj_org_article_603518df68d54c8c82820f9b6372065e pubmedcentral_primary_oai_pubmedcentral_nih_gov_4863962 proquest_miscellaneous_1808637994 proquest_miscellaneous_1789037789 proquest_journals_1797504542 gale_infotracmisc_A479532954 gale_infotracacademiconefile_A479532954 gale_incontextgauss_ISR_A479532954 gale_incontextgauss_ISN_A479532954 pubmed_primary_27168185 crossref_primary_10_1371_journal_ppat_1005615 crossref_citationtrail_10_1371_journal_ppat_1005615
PublicationCentury	2000
PublicationDate	2016-05-01
PublicationDateYYYYMMDD	2016-05-01
PublicationDate_xml	– month: 05 year: 2016 text: 2016-05-01 day: 01
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: San Francisco – name: San Francisco, CA USA
PublicationTitle	PLoS pathogens
PublicationTitleAlternate	PLoS Pathog
PublicationYear	2016
Publisher	Public Library of Science Public Library of Science (PLoS)
Publisher_xml	– name: Public Library of Science – name: Public Library of Science (PLoS)
References	HC Morse 3rd (ref8) 1992; 6 L Huang (ref15) 2012; 188 DH Munn (ref16) 2004; 114 B Baban (ref14) 2005; 17 W Chen (ref30) 2008; 181 M O'Connor (ref7) 2013; 10 M Tal (ref36) 1994; 57 R Vellucci (ref2) 2012; 32 S Fukui (ref33) 1991; 56 BD Ehst (ref18) 2003; 3 F Fallarino (ref26) 2003; 4 WP Rowe (ref35) 1970; 42 D Fornasari (ref3) 2012; 32 BA Johnson 3rd (ref21) 2010; 107 AV Rubtsov (ref23) 2011; 118 L Huang (ref5) 2013; 8 L Cao (ref9) 2012; 189 C Simard (ref27) 1997; 71 DH Munn (ref31) 2002; 297 CJ Sindic (ref1) 2013; 26 M Hoshi (ref6) 2010; 185 L Cao (ref10) 2013; 261 K Schroecksnadel (ref12) 2007; 8 W Zhou (ref19) 2015; 46 WJ Cook (ref38) 2003; 108 AL Mellor (ref13) 2005; 175 M Huang (ref17) 1991; 65 LZ Agudelo (ref34) 2014; 159 H Kim (ref4) 2012; 122 I Decosterd (ref37) 2000; 87 TN Jorgensen (ref24) 2010; 184 R Schwarcz (ref32) 1987; 39 L Huang (ref22) 2013; 191 AL Mellor (ref25) 2004; 16 M Hoshi (ref29) 2009; 33 JG Lees (ref20) 2013; 4 A Cerny (ref28) 1990; 171 WR Green (ref11) 1999; 168
References_xml	– volume: 297 start-page: 1867 year: 2002 ident: ref31 article-title: Potential regulatory function of human dendritic cells expressing IDO publication-title: Science doi: 10.1126/science.1073514 – volume: 108 start-page: 49 issue: 1 year: 2003 ident: ref38 article-title: Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR publication-title: Journal of virological methods doi: 10.1016/S0166-0934(02)00256-2 – volume: 175 start-page: 5601 issue: 9 year: 2005 ident: ref13 article-title: Cutting Edge: CpG Oligonucleotides Induce Splenic CD19+ Dendritic Cells to Acquire Potent IDO-Dependent T Cell Regulatory Functions via IFN Type 1 Signaling publication-title: Journal of immunology doi: 10.4049/jimmunol.175.9.5601 – volume: 6 start-page: 607 issue: 7 year: 1992 ident: ref8 article-title: Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS publication-title: AIDS doi: 10.1097/00002030-199207000-00001 – volume: 185 start-page: 3305 issue: 6 year: 2010 ident: ref6 article-title: The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse publication-title: Journal of immunology doi: 10.4049/jimmunol.0901150 – volume: 10 start-page: 154 issue: 1 year: 2013 ident: ref7 article-title: The role of indoleamine 2,3-dioxygenase in LP-BPM5 murine retroviral disease progression publication-title: Virology journal doi: 10.1186/1743-422X-10-154 – volume: 65 start-page: 6562 issue: 12 year: 1991 ident: ref17 article-title: The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage publication-title: J Virol doi: 10.1128/JVI.65.12.6562-6571.1991 – volume: 26 start-page: 510 issue: 5 year: 2013 ident: ref1 article-title: Infectious neuropathies publication-title: Current opinion in neurology doi: 10.1097/WCO.0b013e328364c036 – volume: 8 start-page: e66546 issue: 6 year: 2013 ident: ref5 article-title: Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection publication-title: PLoS One doi: 10.1371/journal.pone.0066546 – volume: 181 start-page: 5396 issue: 8 year: 2008 ident: ref30 article-title: The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation publication-title: Journal of immunology doi: 10.4049/jimmunol.181.8.5396 – volume: 17 start-page: 909 year: 2005 ident: ref14 article-title: A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation publication-title: Int Immunol doi: 10.1093/intimm/dxh271 – volume: 42 start-page: 1136 issue: 4 year: 1970 ident: ref35 article-title: Plaque assay techniques for murine leukemia viruses publication-title: Virology doi: 10.1016/0042-6822(70)90362-4 – volume: 114 start-page: 280 year: 2004 ident: ref16 article-title: Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes publication-title: The Journal of clinical investigation doi: 10.1172/JCI200421583 – volume: 168 start-page: 271 year: 1999 ident: ref11 article-title: Cytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape publication-title: Immunological reviews doi: 10.1111/j.1600-065X.1999.tb01298.x – volume: 4 start-page: 1206 year: 2003 ident: ref26 article-title: Modulation of tryptophan catabolism by regulatory T cells publication-title: Nature immunology doi: 10.1038/ni1003 – volume: 71 start-page: 3013 issue: 4 year: 1997 ident: ref27 article-title: Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virus publication-title: J Virol doi: 10.1128/JVI.71.4.3013-3022.1997 – volume: 261 start-page: 37 issue: 1–2 year: 2013 ident: ref10 article-title: Involvement of microglial CD40 in murine retrovirus-induced peripheral neuropathy publication-title: Journal of neuroimmunology doi: 10.1016/j.jneuroim.2013.04.023 – volume: 57 start-page: 375 issue: 3 year: 1994 ident: ref36 article-title: Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve publication-title: Pain doi: 10.1016/0304-3959(94)90013-2 – volume: 189 start-page: 3724 issue: 7 year: 2012 ident: ref9 article-title: Murine immunodeficiency virus-induced peripheral neuropathy and the associated cytokine responses publication-title: Journal of immunology doi: 10.4049/jimmunol.1201313 – volume: 107 start-page: 10644 issue: 23 year: 2010 ident: ref21 article-title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0914347107 – volume: 191 start-page: 3509 issue: 7 year: 2013 ident: ref22 article-title: Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses publication-title: Journal of immunology doi: 10.4049/jimmunol.1301419 – volume: 32 start-page: 3 issue: Suppl 1 year: 2012 ident: ref2 article-title: Heterogeneity of chronic pain publication-title: Clinical drug investigation doi: 10.2165/11630030-000000000-00000 – volume: 39 start-page: 485 issue: 5 year: 1987 ident: ref32 article-title: Hippocampal kynurenines as etiological factors in seizure disorders publication-title: Polish journal of pharmacology and pharmacy – volume: 118 start-page: 1305 issue: 5 year: 2011 ident: ref23 article-title: Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity publication-title: Blood doi: 10.1182/blood-2011-01-331462 – volume: 159 start-page: 33 issue: 1 year: 2014 ident: ref34 article-title: Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression publication-title: Cell doi: 10.1016/j.cell.2014.07.051 – volume: 33 start-page: 39 issue: 1 year: 2009 ident: ref29 article-title: Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity publication-title: Leukemia research doi: 10.1016/j.leukres.2008.05.023 – volume: 87 start-page: 149 issue: 2 year: 2000 ident: ref37 article-title: Spared nerve injury: an animal model of persistent peripheral neuropathic pain publication-title: Pain doi: 10.1016/S0304-3959(00)00276-1 – volume: 56 start-page: 2007 issue: 6 year: 1991 ident: ref33 article-title: Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism publication-title: Journal of neurochemistry doi: 10.1111/j.1471-4159.1991.tb03460.x – volume: 4 start-page: 142 year: 2013 ident: ref20 article-title: Immunotherapy targeting cytokines in neuropathic pain publication-title: Front Pharmacol – volume: 16 start-page: 1391 year: 2004 ident: ref25 article-title: Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase publication-title: Int Immunol doi: 10.1093/intimm/dxh140 – volume: 171 start-page: 315 issue: 1 year: 1990 ident: ref28 article-title: B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome publication-title: The Journal of experimental medicine doi: 10.1084/jem.171.1.315 – volume: 184 start-page: 775 issue: 2 year: 2010 ident: ref24 article-title: Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus publication-title: Journal of immunology doi: 10.4049/jimmunol.0901322 – volume: 46 start-page: 147 year: 2015 ident: ref19 article-title: Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice publication-title: Brain, behavior, and immunity doi: 10.1016/j.bbi.2015.01.013 – volume: 122 start-page: 2940 issue: 8 year: 2012 ident: ref4 article-title: Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression publication-title: The Journal of clinical investigation doi: 10.1172/JCI61884 – volume: 188 start-page: 4913 issue: 10 year: 2012 ident: ref15 article-title: Engineering DNA Nanoparticles as Immunomodulatory Reagents that Activate Regulatory T Cells publication-title: Journal of immunology doi: 10.4049/jimmunol.1103668 – volume: 32 start-page: 45 issue: Suppl 1 year: 2012 ident: ref3 article-title: Pain mechanisms in patients with chronic pain publication-title: Clinical drug investigation doi: 10.2165/11630070-000000000-00000 – volume: 8 start-page: 225 issue: 3 year: 2007 ident: ref12 article-title: Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection publication-title: Curr Drug Metab doi: 10.2174/138920007780362608 – volume: 3 start-page: 1355 issue: 11 year: 2003 ident: ref18 article-title: Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection publication-title: Am J Transplant doi: 10.1046/j.1600-6135.2003.00246.x
SSID	ssj0041316
Score	2.4004831
Snippet	Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic pain... Increased pain sensitivity is a comorbidity associated with many clinical diseases, though the underlying causes are poorly understood. Recently, chronic...
SourceID	plos doaj pubmedcentral proquest gale pubmed crossref
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	e1005615
SubjectTerms	Animals Biology and Life Sciences Brain research Cytokines Disease Models, Animal Enzymes Experiments Flow Cytometry Genetic aspects Health aspects HIV Human immunodeficiency virus Hyperalgesia - enzymology Hyperalgesia - etiology Hypersensitivity Hypotheses Indoleamine-Pyrrole 2,3,-Dioxygenase - biosynthesis Infections Inflammation Influenza Influenza A virus Kynurenine - metabolism Laboratory animals Leukemia Medicine and Health Sciences Mice Orthomyxoviridae Pain Pain management Physiological aspects Polymerase Chain Reaction Research and Analysis Methods Retroviridae Rodents Spinal cord Spleen Tryptophan Virus diseases Virus Diseases - complications Viruses
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQCiQuiHcXCgoIiQuhSRy_juVRtRJaVUCr3iyvY0OkJVltdhH775mJvVGDCr1wiax48vDMZB7y5BtCXqkio9Z7kzrwXmnJxDw11pjUgiGkXkrG-nZv55_EbCYvLtTppVZfWBMW4IED4w44bnXJynNZsdJKCxlCkXk159hehTOH1jcTapdMBRsMlrlveopNcVJBOY8_zVGRH0QZvV0uDcJHYwTNRk6px-4fLPRkuWi7q8LPP6soL7mlo7vkTownk8Owjnvkhmvuk1uhw-T2ATk7r1ebLjmJJVcNDi1EmcmpqZvkGJLQVYcl7KGHRDLfJtjLw4I_w0G7cOYHhKFJ8YYmH-r21xbUDdzeQ3J29PHr--M0dlJILVflOrUCkdyo805axWzFTOWlLxzLcl-Cl_QFF4aWc8YFQsAJBHrLVGaUzbnxqqKPyKRpG7dHEseF4JYLOAuhlMrnzBSVz2mFT3KWTgndsVLbCDOO3S4Wut87E5BuBM5oFICOApiSdLhqGWA2rqF_h1IaaBEkuz8BqqOj6ujrVGdKXqKMNcJgNFhn881suk6ffJnpw1IoRnEP9K9En0dEryORb2Gx1sR_G4BlCK81otwfUcLHbEfTe6hvuzV3GuwlAvCzsoArdzp49fSLYRpvirVzjWs3SCNVRgUc_0EjIbWlQil4g8dBrQfeFpBSY1g3JWKk8CPmj2ea-nuPVF7CTRUvnvwPaT0ltyFY5aHYdJ9M1quNe0Zu2p_ruls97z__36rlXA8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Library of Science (PLoS) Journals Open Access dbid: FPL link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELeggLQXvmGFgQJC4oVAEsd2_Dg-qk2aqgrYtDfLcWyI1CVV0yL633OXuIFMK4iXKIrPSXy5T_nyO0JeySSixjkdWvBeYcpEHmqjdWjAEFKXZYy17d7OTsR0mp2fy9nvRPHSDj4V8TvP07eLhUa4Z4x42XVyI6GcY7I1mZ1sLS_Y45j73-N2zRy4nxalv7fFo8W8bq4KNC_XS_7hgCZ3_vfV75LbPtQMDjvZuEeu2eo-udU1n9w8IKdn5XLdBMe-GqvCUwMBaDDTZRUcQX66bLC6vWsvEeSbANt8GHB1eFLPrb6ACDVI3tDgY1n_3IAkgkd8SE4nn75-OAp9k4XQcJmuQiMQ5I1aZzMjmSmYLlzmEsui2KXgQF3ChaZpzrhAdDiBGHCRjLQ0MddOFvQRGVV1ZfdJYLkQ3HABVyHKknHOdFK4mBb4JGvomNAt75XxCOTYCGOu2m01AZlIxxmFDFOeYWMS9rMWHQLHP-jf42ftaRE_u70AX0Z5dVQcN1CzwvGsYKnJDOSdSeRkzrFpD2d2TF6iUChEyKiwBOebXjeNOv4yVYepkIzi9uhOos8DoteeyNWwWKP9bw_AMkTeGlAeDChBz81geB8FdLvmRoEpRWx-liYwcyu0Vw-_6IfxplhWV9l6jTSZjKiA419oMsh6qZAS3uBxpwc9bxPItjHiGxMx0JAB84cjVfm9BTFP4aaSJ092r-op2YPolHfVpQdktFqu7TNy0_xYlc3yeav5vwAvSlfV priority: 102 providerName: Public Library of Science
Title	Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase
URI	https://www.ncbi.nlm.nih.gov/pubmed/27168185 https://www.proquest.com/docview/1797504542 https://www.proquest.com/docview/1789037789 https://www.proquest.com/docview/1808637994 https://pubmed.ncbi.nlm.nih.gov/PMC4863962 https://doaj.org/article/603518df68d54c8c82820f9b6372065e http://dx.doi.org/10.1371/journal.ppat.1005615
Volume	12
WOSCitedRecordID	wos000379344500023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1553-7374 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0041316 issn: 1553-7374 databaseCode: DOA dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1553-7374 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0041316 issn: 1553-7374 databaseCode: M7P dateStart: 20050901 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1553-7374 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0041316 issn: 1553-7374 databaseCode: 7X7 dateStart: 20050901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1553-7374 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0041316 issn: 1553-7374 databaseCode: BENPR dateStart: 20050901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content customDbUrl: eissn: 1553-7374 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0041316 issn: 1553-7374 databaseCode: PIMPY dateStart: 20050901 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1553-7374 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0041316 issn: 1553-7374 databaseCode: FPL dateStart: 20050101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdYBxIvfMMKowoIiReypXH89YQ22LRKo4oGm8pT5Dr2qFSS0rSI_vfcJW4haIwHXqwod3Fi-3x3ti-_I-SViiNqnNOhBesVJkyMQ220Dg0oQuqkZKxO93ZxKoZDORqp1G-4VT6scq0Ta0Wdlwb3yPdBcBCJnCXx29m3ELNG4emqT6GxRbYRJSGuQ_fStSYG_VynPsXUOKGgnPtf56jo7_uR2pvNNIJIox_NWqapRvDf6OnObFpWVzmhf8ZS_macju_-b7PukTveLQ0OGjm6T27Y4gG51SSqXD0k5xeT-bIKBj5yq8BLAzUEqZ4UwQmsZecVRsI3qSiC8SrAlCAGzCJelFOrv4I3G8RvaPB-Uv5YgdSC9XxEzo-PPr07CX1ChtBwlSxCIxAQjlpnpVHM5EznTrrYsqjvEjC2LuZC02TMuEAkOYF4cZGKtDJ9rp3K6WPSKcrC7pDAciG44QLugkem-mOm49z1aY5vsoZ2CV2PRWY8WjkmzZhm9RGcgFVL0zMZjmDmR7BLws1Tswat4x_8hzjMG17E2q5vlPPLzE_djONhq8wdlzlLjDSwRo0jp8YcE_xwZrvkJQpJhmgaBYbrXOplVWWDj8PsIBGKUTxK_SvTWYvptWdyJTTWaP-LBHQZonS1OHdbnKATTIu8gwK7bnOV_RIzeHItiFeTX2zIWCmG4BW2XCKPVBEVUF7DI2GFTIVS8AVPmnmx6dsYVuboHXaJaM2YVue3KcXkSw14nkClisdPr__0Z-Q2eLO8iUbdJZ3FfGmfk5vm-2JSzXtkS4xEXcoe2T48GqZnvXoDBsrj9LRXaw6gpIMP6eefNjFygg
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFLdGB4IL32OFAQGBdiFbEsd2fEBoMKZW66oKtmmcguvYo1JJStMC_af4G3kvH4WgMU47cKmi-MWxX96X6-f3I-SZDDyqrVWuAe_lhkwMXaWVcjUYQmqjiLEC7u24J_r96OREDlbIj_osDKZV1jaxMNRJpvE_8m0QHKxEzsLg1eSLi6hRuLtaQ2iUYrFvFt9gyZa_7O7C930eBHtvD9903ApVwNVchjNXC6xqRo01kZZMJ0wlNrKBYZ5vQ_AYNuBC0XDIuMByaAKLnnnSU1L7XFmZUOj3ElkNUdhbZHXQPRh8qG0_eIQCbBXBeFxBOa8O61Hhb1eysTWZKCxbjZE7azjDAjNg6Rlak3GWnxX2_pm9-Zs73LvxvzHyJrleBd7OTqkpt8iKSW-TKyUU5-IOOToeTee5061y01K81DBiZ6BGqdOB1fo0x1z_EmzDGS4cBD3R4PjxIhsb9RnidSd4QZ3dUfZ9AXoJ8cFdcnQhc1ojrTRLzTpxDBeCay7gLsSc0h8yFSTWpwm-yWjaJrT-9rGu6rEjLMg4LjYZBazLSs7EKDFxJTFt4i6fmpT1SP5B_xrFakmL1cSLG9n0NK6MU8xxOzlKLI8SFupIwyo88KwccoQw4sy0yVMUyhjrhaSYkHSq5nked9_3451QSEZxs_ivRO8aRJsVkc1gslpVh0CAZViHrEG50aAEq6cbzeuoIPWc8_iXWMOTteCf3fxk2YydYpJharI50kTSowJ-z6GJvAjYIiWM4F6ph0veBsLnGP-2iWhoaIP5zZZ09Kko6R5Cp5IH988f-mNytXN40It73f7-A3INYnde5t5ukNZsOjcPyWX9dTbKp48qu-SQjxetwT8BuXnJmQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFLdGB4gL37DCgIBAXAhN7diODwgNyrRqo6pgm8YpuI49KpWkNC3Qf42_jvfyUQga47QDlyiKX1z75X25fn4_Qh4rGjDjnPYteC8_5HLka6O1b8AQMhdFnBdwb4d7cjCIjo7UcI38qM_CYFplbRMLQ51kBv8j74DgYCVyHtKOq9Iihr3tl9MvPiJI4U5rDadRisiuXX6D5Vv-ot-Db_2E0u03-693_AphwDdChXPfSKxwxqyzkVHcJFwnLnLU8qDrQvAejgqpWTjiQmJpNIkF0AIVaGW6QjuVMOj3HFmHkDykLbI-7L8dfqj9AHiHAngVgXl8yYSoDu4x2e1UcvJ8OtVYwhqjeN5wjAV-wMpLtKaTLD8pBP4zk_M317h95X9m6lVyuQrIva1Sg66RNZteJxdKiM7lDXJwOJ4tcq9f5ayleGtgxN5Qj1NvB1bxsxzPAJQgHN5o6SEYioGAAG-yidWfIY736DPm9cbZ9yXoK8QNN8nBmczpFmmlWWo3iGeFlMIICU8hFlXdEdc0cV2W4C9Zw9qE1XIQm6pOO8KFTOJi81HCeq3kTIzSE1fS0yb-6q1pWafkH_SvUMRWtFhlvHiQzY7jymjFAreZo8SJKOGhiQyszmng1EggtJHgtk0eoYDGWEckReE51os8j_vvB_FWKBVnuIn8V6J3DaKnFZHLYLJGV4dDgGVYn6xBudmgBGtoGs0bqCz1nPP4l4jDm7USnNz8cNWMnWLyYWqzBdJEKmASrqfQREEEbFEKRnC71MkVb6nsCoyL20Q2tLXB_GZLOv5UlHoPoVMl6J3Th_6AXAS1jff6g9275BKE9KJMyd0krflsYe-R8-brfJzP7lcmyiMfz1qBfwLw1NJZ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Virus+Infections+Incite+Pain+Hypersensitivity+by+Inducing+Indoleamine+2%2C3+Dioxygenase&rft.jtitle=PLoS+pathogens&rft.au=Huang%2C+Lei&rft.au=Ou%2C+Rong&rft.au=Souza%2C+Guilherme+Rabelode&rft.au=Cunha%2C+Thiago+M&rft.date=2016-05-01&rft.eissn=1553-7374&rft.volume=12&rft.issue=5&rft_id=info:doi/10.1371%2Fjournal.ppat.1005615&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon